Invivo Anti-Mouse CD200 (OX2) Recombinant mAb (S-R739)

產(chǎn)品型號(hào)：S0B7001

更新時(shí)間：2025-07-15

廠商性質(zhì)：生產(chǎn)廠家

訪問量：83

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

斯達(dá)特特色產(chǎn)品推薦之：PD-1 功能性抗體

IHC腫瘤標(biāo)志物 | 常見胃癌和結(jié)直腸癌診斷

蛋白翻譯后修飾新貴：猶素化（UFMylation）

PLA技術(shù)+蛋白翻譯后修飾（PTMs）研究，蛋白研究新CP！

產(chǎn)品介紹

CD200 （OX2） protein is a type-1 membrane glycoprotein belonging to the immunoglobulin superfamily, widely distributed on various cell types including thymocytes, neurons, endothelial cells, and immune cells such as macrophages and dendritic cells. It plays a crucial role in immune regulation by interacting with its receptor CD200R, which is highly expressed on myeloid cells and some lymphoid cells. The CD200-CD200R interaction inhibits inflammatory responses, promotes immune tolerance, and helps maintain tissue homeostasis. In cancer, CD200 is often overexpressed on tumor cells, contributing to immune evasion by suppressing anti-tumor immune responses. Additionally, elevated levels of soluble CD200 （sCD200） in serum are associated with adverse tumor prognosis in several cancers.

上一個(gè)：S0E1002Alexa Fluor? 488 Antibody Labeling Kit